John McHutchison appointed CEO and Chairman of Tune Therapeutics

Tune Therapeutics

Tune Therapeutics named Dr. John McHutchison as CEO and Chairman of the Board, bringing decades of experience in antiviral drug development and clinical trials. McHutchison previously led research and development at Gilead Sciences and served as CEO of Assembly Biosciences.

• Dr. John McHutchison, experienced antiviral drug developer, appointed CEO and Chairman.
• McHutchison has deep experience in hepatitis research and drug development from prior roles.
• Leadership change reflects the company's transition to clinical-stage operations.